Nomura cuts New China Life (01336) to HK$76.67
|
Nomura lowered its target price for New China Life (NCI)(01336) to HK$76.67 from HK$78.11, and reiterated its "buy/outperform" rating. The research house lowered its FY2017 NBV growth forecast by 7% due to the negative impact from the tightening of regulations since 4Q 2017, but increased its FY2017 earnings forecast by 3% given its strong financial performance. With the first two months of 2018 total premiums only growing by 3%, Nomura expects NBV to grow 19% in FY2017. But it believes the premium growth would gradually stabilise from 2Q 2018 as the company gradually shifts its focus to the protection business and increasing its agent team. |
Comments
Post a Comment